Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections

References

• JhonsonMADrewWLRobertsMBranhamella (Neisseria) catarrhalis – a lower respiratory tract pathogen?J Clin Microbiol198113106610697251828
   PubMed Web of Science ®Google Scholar
• AebiCMoraxella catarrhalis – pathogen or commensal?Adv Exp Med Biol201169710711621120723
   PubMed Web of Science ®Google Scholar
• BrooksGFCarrollKCButelJSMorseSAMietznerTAChapter 16. Pseudomonas, acinetobacter, and uncommon gram-negative bacteriaJawetz, Melnick, and Adelberg’s Medical Microbiology26 ed.2013 Available from: http://www.accessmedicine.com/content.aspx?aID=57032597Accessed November 17, 2013
   Google Scholar
• SyMGRobinsonJLCommunity-acquired Moraxella catarrhalis pneumonia in previously healthy childrenPediatr Pulmonol20104567467820575092
   PubMed Web of Science ®Google Scholar
• WallaceRJJrSteingrubeVANashDRBRO beta lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta lactamases transfer by conjugation in B. catrarrhalis, M. nonliquefaciens, and M. lacunataAntimicrob Agents Chemother199833184518542514622
   PubMed Web of Science ®Google Scholar
• KhanMANorthwoodJBLevyFBRO beta lactamases and antibiotic resistances in a global cross sectional study of Moraxella catarrhalis from children and adultsJ Antimicrob Chemother201065919719889789
   PubMed Web of Science ®Google Scholar
• WrightPWWallaceRJJrShepherdJRA descriptive study of 42 cases of Branhamella catarrhalis pneumoniaAm J Med1990885A2S8S2111088
   PubMed Web of Science ®Google Scholar
• TamangMDDeySMakajuRKJhaBKShivanandaPGBhramadatanKNPrevalence of Moraxella catarrhalis infections of the lower respiratory tract in elderly patientsKathmandu Univ Med J2005393944
   Google Scholar
• AbdullahFEAhjuaKRKumarHPrevalence and emerging resistance of Moraxella catarrhalis in lower respiratory tract infection in KarachiJ Pak Med Assoc201363111342134424392515
   PubMed Web of Science ®Google Scholar
• ButtTRafiNAhmedSAhmedRNSalmanMMirzaSHCommunity acquired pneumonia in RawalpindiPak J Pathol200516614
   Google Scholar
• DorenGVJonesRNPfallerMAKuglerKThe Sentry Participant GroupHemophilis influenza and Moraxella catarrhalis from patients with community acquired respiratory tract infections: antimicrobial susceptibility patterns from SENTRY antimicrobials surveillance program (United States and Canada, 1997)Antimicrob Agents Chemother1999433853899925540
   PubMed Web of Science ®Google Scholar
• JonesRNJacobsMRWashingtonJAPfallerMAA 1994–1995 survey of Hemophilus influenza susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United StatesDiagn Microbiol Infect Dis19972775839147008
   PubMed Web of Science ®Google Scholar
• DorenGVBrueggemannABPierceGHolleyHPRauchAPrevalence of antimicrobial resistance among 723 out patient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30 center national surveillance studyAntimicrob Agents Chemother199640288428869124860
   PubMed Web of Science ®Google Scholar
• SchmitzFJBeeckAPerdikouliMProduction of BRO beta lactamases and resistance to complement in European Moraxella isolatesJ Clin Microbiol2002401546154811923393
   PubMed Web of Science ®Google Scholar
• WalkerESPrestonRAPostJCEhriicGDKalbfleischJHKingmanKLGenetic diversity among strains of Moraxella catarrhalis: analysis using multiple DNA probes and a single locus PCR restriction fragment length polymorphism methodJ Clin Microbiol199838197719839650948
   PubMed Web of Science ®Google Scholar
• HunterMHKingDECOPD: management of acute exacerbations and chronic stable diseaseAm Fam Physician200164460361211529259
   PubMed Web of Science ®Google Scholar
• LiebermanDLiebermanDBen-YaakovMInfectious etiologies in acute exacerbation of COPDDiagn Microbiol Infect Dis20014039510211502375
   PubMed Web of Science ®Google Scholar
• SethiSMurphyTFBacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art reviewClin Microbiol Rev200114233636311292642
   PubMed Web of Science ®Google Scholar
• YEFHeLXCaiBQSpectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of ChinaChin Med J2013126122207221423786927
   PubMed Web of Science ®Google Scholar
• DomenechAPuigCMartíSInfectious etiology of acute exacerbations in severe COPD patientsJ Infect20136751652324055804
   PubMed Web of Science ®Google Scholar
• HsuSFLinYTChenTLAntimicrobial resistance of Moraxella catarrhalis isolates in TaiwanJ Microbiol Immunol Infect20124513414022154675
   PubMedGoogle Scholar
• TabassumNAhmedADetermination of anti-microbial susceptibilities of H. Influenza, S. pneumonia and M. catarrhalisJ Pak Med Assoc200252879012073719
   PubMedGoogle Scholar
• LevisonMEPneumonia including necrotizing pulmonary infections (lung abscess)FauciASBraunwaldEIsselbacherKJWilsonJDMartinJBKasperDLHarrison’s Principles of Internal Medicine14th edNew YorkMc Graw Hill199814371445
   Google Scholar
• SugiyamaHOgataEShimamotoYMoraxella catarrhalis pneumonia in a patient with immunoglobulin deficiencyJ Infect Chemother20006616211810533
   PubMedGoogle Scholar
• BandakSITurnakMRAllenBSAntibiotic susceptibilities among recent clinical isolates of H. influenzae and Moraxella catarrhalis from fifteen countriesEur J Clin Microbiol Infect Dis200120556011245326
   PubMed Web of Science ®Google Scholar
• SwansonRNLainez-VentosillaADe SalvoMCDunneMWAmsdenGWOnce daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: multicenter, double-blind, randomized studyTreat Respir Med200541313915725048
   PubMedGoogle Scholar
• YoshidaKOkimotoNKishimotoMEfficacy and safety of moxifloxacin for community acquired bacterial pneumonia based on pharmacokinetic analysisJ Infect Chemother201117567868521847518
   PubMed Web of Science ®Google Scholar
• GilbertDNMoelleringRCJrChambersHFSaagMSThe Sanford Guide to Antimicrobial Therapy43 edSperryvilleAntimicrobial Therapy Inc2013
   Google Scholar